Citation Impact
Citing Papers
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Hepatocellular carcinoma
2003 Standout
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota
1993
Hydrogels in Regenerative Medicine
2009 Standout
Evaluation and stages of surgical innovations
2009 Standout
Islet Transplantation as a Treatment for Diabetes — A Work in Progress
2004
Liver transplantation for cholangiocellular carcinoma: Analysis of a single-center experience and review of the literature
2001
PREGNANCY AFTER LIVER TRANSPLANTATION UNDER TACROLIMUS1
1997
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*
1997 Standout
CD28-B7 interactions in T-cell activation
1994 StandoutNobel
Clinical Pharmacokinetics in Organ Transplant Patients
1989
SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506
1990
VARIABLES IN ORGAN DONORS THAT AFFECT THE RECOVERY OF HUMAN ISLETS OF LANGERHANS1
1996
Tacrolimus
1993
Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing
1988
Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver
2001 StandoutNobel
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
1989 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Neuroendocrine gastrointestinal tumours
1996
A Risk-Benefit Assessment of Tacrolimus in Transplantation
1995
Alginate: Properties and biomedical applications
2011 Standout
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
Extended Resections for Hilar Cholangiocarcinoma
1999
CTLA-4 can function as a negative regulator of T cell activation
1994 Standout
Is Liver Transplantation Justified for the Treatment of Hepatic Malignancies?
1990
Liver Resection for Hilar and Peripheral Cholangiocarcinomas: A Study of 62 Cases
1998
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
1995 Standout
Tacrolimus
1997
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Intestinal Transplantation in Composite Visceral Grafts or Alone
1992
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Alginate coating of islets of Langerhans: in vitro studies on a new method for microencapsulation for immuno-isolated transplantation
1992
The mitochondrial permeability transition
1995 Standout
The Role of CTLA‐4 in the Regulation and Initiation of T‐Cell Responses
1996 StandoutNobel
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Pediatric intestinal transplantation: Historical notes, principles and controversies
2002
THE EFFECT OF BILE DUCT LIGATION AND BILE DIVERSION ON FK506 PHARMACOKINETICS IN DOGS
1992
Cholangiocarcinoma
2007 Standout
Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma
1997
Long-term Functioning of Allogeneic Islets in Subcutaneous Tissue Pretreated With a Novel Cyclic Peptide Without Immunosuppressive Medication
2017 StandoutNobel
Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A
1994
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
1998 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Self‐assembly of peptide amphiphiles: From molecules to nanostructures to biomaterials
2010 Standout
Is surgical science dead?
2003
Infection in Organ-Transplant Recipients
1998 Standout
Cell migration, chimerism, and graft acceptance
1992 Standout
Epstein–Barr Virus Infection
2000 Standout
Monitoring of Tacrolimus as Rescue Therapy in Pediatric Liver Transplantation
1998
OUTCOME OF SUBCUTANEOUS ISLET TRANSPLANTATION IMPROVED BY POLYMER DEVICE1
1996
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
1991
Tissue Engineering
1993 StandoutScience
FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats
1991
Biliary complications in pediatric living related liver transplantation
1998 StandoutNobel
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
1995 StandoutNobel
CD28/B7 SYSTEM OF T CELL COSTIMULATION
1996 Standout
Surgical treatment of cholangiocellular carcinoma
1995
Tacrolimus
2000
THE EVOLUTION OF IMMUNOSUPPRESSION WITH FK506 IN PEDIATRIC LIVING-RELATED LIVER TRANSPLANTATION1
1996
Maintenance of Normoglycemia in Diabetic Mice by Subcutaneous Xenografts of Encapsulated Islets
1991 Science
Primary hepatic malignancy: The role of liver transplantation
1990
Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
1991
Biopharmaceutical aspects of FK-506.
1987
The many faces of multivisceral transplantation.
1991
Use of FK 506 in pediatric patients.
1991
Kidney Transplantation Under FK 506
1990
The effect of prednisone on pancreatic islet autografts in dogs.
1993
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
1990
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
1992 StandoutScience
Two-year experience with FK 506 in pediatric patients.
1993
FK506 and pregnancy in liver transplant patients.
1993
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Liver transplantation for hepatocellular carcinoma
1995
Indications for liver transplantation in hepatobiliary malignancy
1994
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts.
1990
Intestinal and Multivisceral Transplantation
2002
Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.
1991
Analysis of the Underlying Cellular Mechanisms of Anti-CD154-Induced Graft Tolerance: The Interplay of Clonal Anergy and Immune Regulation
2005 StandoutNobel
Comparison of Intravenous Ganciclovir Followed by Oral Acyclovir with Intravenous Ganciclovir Alone for Prevention of Cytomegalovirus and Epstein‐Barr Virus Disease After Liver Transplantation in Children
1997
Works of S Todo being referenced
Abdominal Organ Cluster Transplantation for the Treatment of Upper Abdominal Malignancies
1989
Single-Center Experience With Pimary Orthotopic Liver Transplation with FK 506 Immunosuppression
1994
Tube Choledochoureterostomy: A Simple Method for Bile Diversion
1990
CHILDBEARING AFTER LIVER TRANSPLANTATION
1990
Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement
1990
Comparative pharmacokinetics of cyclosporine and NVa2-cyclosporine in dogs.
1987
Role of bile and bile salts on cyclosporine absorption in dogs.
1987
Piggyback orthotopic intestinal transplantation.
1993
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.
1987
Studies of the hepatotrophic qualities of FK 506 and CyA.
1990